Exodus Point Capital Management, LP Vista Gen Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.14 - $4.8 $5,061 - $173,553	-36,157 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$0.88 - $1.73 $28,503 - $56,034	-32,390 Reduced 47.25%	36,157 $32,000
Q1 2022 May 13, 2022	BUY	$1.14 - $2.09 $64,463 - $118,183	56,547 Added 471.23%	68,547 $85,000
Q4 2021 Feb 11, 2022	BUY	$1.67 - $2.76 $20,040 - $33,120	12,000 New	12,000 $23,000
Q2 2021 Aug 16, 2021	SELL	$1.96 - $3.15 $629,301 - $1.01 Million	-321,072 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $170,179 - $266,524	90,042 Added 38.97%	321,072 $684,000
Q4 2020 Feb 16, 2021	BUY	$0.65 - $1.94 $150,169 - $448,198	231,030 New	231,030 $448,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.